- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07617857
Whole-Body Cryotherapy and Isokinetic Performance After Exercise-Induced Fatigue (WBC-ISO)
Effect of Whole-Body Cryotherapy on Isokinetic Performance After Exercise-Induced Fatigue
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This study was designed to investigate the effects of whole-body cryotherapy (WBC) on recovery and isokinetic muscle performance following exercise-induced fatigue in physically active healthy male university students. Exercise-induced fatigue is associated with reduced muscle force production, impaired performance, and increased injury risk. Various recovery strategies have been used to minimize these negative effects, and WBC has gained increasing attention in sports medicine because of its potential physiological and neuromuscular recovery benefits.
The study used a randomized within-subject crossover design in which participants completed two recovery conditions, WBC and passive rest, on separate days following a standardized treadmill-based fatigue protocol. During the WBC condition, participants were exposed to a two-stage cryogenic chamber consisting of an adaptation chamber at -30°C followed by a main chamber at -85°C. Passive rest sessions were performed under the same laboratory conditions without cryotherapy exposure.
Primary outcome measures included isokinetic knee extension and flexion performance assessed at angular velocities of 60°/s and 240°/s using an isokinetic dynamometer. Peak torque and body mass-normalized peak torque values were analyzed for both dominant and non-dominant lower extremities. Secondary outcome measures included systolic and diastolic blood pressure, heart rate, oxygen saturation, and perceived fatigue responses measured throughout the recovery period.
The aim of the study was to determine whether WBC provides superior recovery effects compared with passive rest following running-induced acute fatigue.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Istanbul
-
Istanbul, Istanbul, Turquía (Türkiye), 34000
- Istanbul University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Healthy male participants aged 18-30 years with no exercise limitation
- No history of knee or lower-extremity injury requiring physiotherapy or surgical intervention
- No current lower-extremity pain
- No limitation in lower-extremity range of motion
- No chronic disease
- No mental or psychological disorder
Exclusion Criteria:
- Presence of cardiovascular disease
- Presence of respiratory disease
- History of cold allergy
- Presence of a tumor-related disease
- Presence of a viral or bacterial infection
- Diagnosis of Raynaud's disease
- Presence of claustrophobia
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Whole-Body Cryotherapy
Participants underwent whole-body cryotherapy following the running-induced fatigue protocol.
|
Participants underwent whole-body cryotherapy following a standardized running-induced fatigue protocol.
The intervention was performed in a two-stage cryogenic chamber consisting of a 30-second adaptation phase at -30°C followed by a 3-minute exposure at -85°C.
|
|
Sin intervención: Passive Rest
Participants completed passive seated rest following the running-induced fatigue protocol.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Peak Torque During Knee Extension and Flexion
Periodo de tiempo: Immediately after the 30-minute recovery period
|
Assessment of isokinetic knee extension and flexion peak torque at 60°/s and 240°/s following whole-body cryotherapy and passive rest recovery conditions.
|
Immediately after the 30-minute recovery period
|
|
Peak Torque Normalized to Body Mass
Periodo de tiempo: Immediately after the 30-minute recovery period
|
Assessment of body mass-normalized peak torque values during isokinetic knee extension and flexion testing at 60°/s and 240°/s.
|
Immediately after the 30-minute recovery period
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Heart Rate
Periodo de tiempo: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
Assessment of heart rate responses throughout the recovery period following exercise-induced fatigue.
|
Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
|
Blood Pressure
Periodo de tiempo: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
Assessment of systolic and diastolic blood pressure responses throughout the recovery period.
|
Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
|
Oxygen Saturation
Periodo de tiempo: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
Assessment of peripheral oxygen saturation during the recovery period.
|
Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
|
|
Perceived Fatigue
Periodo de tiempo: Immediately after exercise, 5 minutes, and 10 minutes after exercise
|
Assessment of perceived fatigue using the Borg Rating of Perceived Exertion (RPE) Scale (6-20 points).
Scores range from 6 (no exertion) to 20 (maximal exertion), with higher scores indicating greater perceived fatigue and exertion.
|
Immediately after exercise, 5 minutes, and 10 minutes after exercise
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Krueger M, Costello JT, Achtzehn S, Dittmar KH, Mester J. Whole-body cryotherapy (-110 degrees C) following high-intensity intermittent exercise does not alter hormonal, inflammatory or muscle damage biomarkers in trained males. Cytokine. 2019 Jan;113:277-284. doi: 10.1016/j.cyto.2018.07.018. Epub 2018 Jul 19.
- Abaidia AE, Lamblin J, Delecroix B, Leduc C, McCall A, Nedelec M, Dawson B, Baquet G, Dupont G. Recovery From Exercise-Induced Muscle Damage: Cold-Water Immersion Versus Whole-Body Cryotherapy. Int J Sports Physiol Perform. 2017 Mar;12(3):402-409. doi: 10.1123/ijspp.2016-0186. Epub 2016 Aug 24.
- Wilson LJ, Cockburn E, Paice K, Sinclair S, Faki T, Hills FA, Gondek MB, Wood A, Dimitriou L. Recovery following a marathon: a comparison of cold water immersion, whole body cryotherapy and a placebo control. Eur J Appl Physiol. 2018 Jan;118(1):153-163. doi: 10.1007/s00421-017-3757-z. Epub 2017 Nov 10.
- Rose C, Edwards KM, Siegler J, Graham K, Caillaud C. Whole-body Cryotherapy as a Recovery Technique after Exercise: A Review of the Literature. Int J Sports Med. 2017 Dec;38(14):1049-1060. doi: 10.1055/s-0043-114861. Epub 2017 Nov 21.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 2024/1567
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .